CRA is a proud sponsor of this event.
Ashley Fraser is moderating a panel that will discuss how to “Prepare your Organization for Changes to Canada’s Drug Procurement Strategy.”
For more information on this event, click here.
Beyond the single asset: The rise of combination and synergistic innovation in neurology drug development
Introduction Historically, drug development within the neurology space has been characterized by the search for individual therapies that can arrest complex...